Cell and gene therapies / ATMPs
Cell and gene therapies represent a revolutionary class of biotherapeutics designed to treat, prevent, or even cure a wide range of diseases. At Quality Assistance, we focus on mRNA, viral vectors and cell-based therapies, each offering unique mechanisms of therapeutic intervention.
These advanced therapies are being developed to address some of the most challenging medical conditions, including cancer, autoimmune diseases and genetic disorders.
As the therapeutic landscape evolves, so does the need for a reliable scientific partner who understands the complexity and regulatory demands of these products.
Related products
Related services
Why partner with us for your cell-based medicine development?
With over 12 years of experience in cell and gene therapies, Quality Assistance is your strategic partner in bringing innovative medicines to market. We offer a fully integrated analytical solution tailored to the unique challenges of of both gene- and cell-based therapies.
What sets us apart?
- One site, one system: all laboratories operate on a single, dedicated site. This eliminates logistical delays and risks associated with sample transfer. It also guarantees a faster and controlled time-to-results pipeline
- Uncompromising compliance: we operate under a robust Full GxP framework. This ensures that every analytical step meets the current requirements of the EMA, FDA and ICH standards
- Customised solutions: we design and validate custom analytical methods to overcome the unique challenges of cell and gene therapies
- Scientific partnership: we become an extension of your team, helping you navigate the evolving cell and gene therapies regulations to accelerate your product’s path to market
Your committed partner in innovation
Our mission is to help you deliver safe, effective and high-quality therapies that change patients’ lives. By choosing Quality Assistance, you gain more than the analytical support, you gain a committed partner in innovation.
Discuss your project with an expert